A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?
- PMID: 28443205
- PMCID: PMC5365183
- DOI: 10.20892/j.issn.2095-3941.2017.0006
A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?
Abstract
Objective: Intra-abdominal fat is a risk factor for pancreatic cancer (PC), but little is known about its contribution to PC precursors known as intraductal papillary mucinous neoplasms (IPMNs). Our goal was to evaluate quantitative radiologic measures of abdominal/visceral obesity as possible diagnostic markers of IPMN severity/pathology.
Methods: In a cohort of 34 surgically-resected, pathologically-confirmed IPMNs (17 benign; 17 malignant) with preoperative abdominal computed tomography (CT) images, we calculated body mass index (BMI) and four radiologic measures of obesity: total abdominal fat (TAF) area, visceral fat area (VFA), subcutaneous fat area (SFA), and visceral to subcutaneous fat ratio (V/S). Measures were compared between groups using Wilcoxon two-sample exact tests and other metrics.
Results: Mean BMI for individuals with malignant IPMNs (28.9 kg/m2) was higher than mean BMI for those with benign IPMNs (25.8 kg/m2) (P=0.045). Mean VFA was higher for patients with malignant IPMNs (199.3 cm2) compared to benign IPMNs (120.4 cm2),P=0.092. V/S was significantly higher (P=0.013) for patients with malignant versus benign IPMNs (1.25vs. 0.69 cm2), especially among females. The accuracy, sensitivity, specificity, and positive and negative predictive value of V/S in predicting malignant IPMN pathology were 74%, 71%, 76%, 75%, and 72%, respectively.
Conclusions: Preliminary findings suggest measures of visceral fat from routine medical images may help predict IPMN pathology, acting as potential noninvasive diagnostic adjuncts for management and targets for intervention that may be more biologically-relevant than BMI. Further investigation of gender-specific associations in larger, prospective IPMN cohorts is warranted to validate and expand upon these observations.
Keywords: Abdominal obesity; computed tomography; pancreatic cancer; pre-malignant lesions.
Figures

Similar articles
-
Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms.Oncotarget. 2016 Dec 27;7(52):85785-85797. doi: 10.18632/oncotarget.11768. Oncotarget. 2016. PMID: 27589689 Free PMC article.
-
Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.Ann Nucl Med. 2011 Aug;25(7):501-10. doi: 10.1007/s12149-011-0494-y. Epub 2011 May 3. Ann Nucl Med. 2011. PMID: 21537945
-
Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.Gastrointest Endosc. 2016 Sep;84(3):436-45. doi: 10.1016/j.gie.2016.02.008. Epub 2016 Feb 18. Gastrointest Endosc. 2016. PMID: 26905937
-
Intraductal papillary mucinous neoplasm--when to resect?Adv Surg. 2008;42:87-108. doi: 10.1016/j.yasu.2008.03.011. Adv Surg. 2008. PMID: 18953811 Review.
-
Uptodate in the assessment and management of intraductal papillary mucinous neoplasms of the pancreas.Eur Rev Med Pharmacol Sci. 2017 Jun;21(12):2858-2874. Eur Rev Med Pharmacol Sci. 2017. PMID: 28682431 Review.
Cited by
-
Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas.Front Oncol. 2021 Jul 22;11:712950. doi: 10.3389/fonc.2021.712950. eCollection 2021. Front Oncol. 2021. PMID: 34367997 Free PMC article.
-
Effect of Intravenous Contrast on CT Body Composition Measurements in Patients with Intraductal Papillary Mucinous Neoplasm.Diagnostics (Basel). 2024 Nov 18;14(22):2593. doi: 10.3390/diagnostics14222593. Diagnostics (Basel). 2024. PMID: 39594259 Free PMC article.
-
A new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms.Cancer Biol Med. 2018 Feb;15(1):70-78. doi: 10.20892/j.issn.2095-3941.2017.0152. Cancer Biol Med. 2018. PMID: 29545970 Free PMC article.
References
-
- Yeo TP. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma. Semin Oncol. 2015;42:8–18. - PubMed
-
-
Marmot M, Atinmo T, Byers T, Chen J, Hirohata T, Jackson A, et al. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, 2007. (请核对作者及出版地)
-
-
- Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44:186–98. - PubMed
-
- Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control. 2000;11:915–23. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources